| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977895 | Brachytherapy | 2012 | 8 Pages |
Abstract
The MC-predicted dose distribution of the AgX100 seed was found to be comparable with that of the model 6711 seed but much different from the dose distribution of the model I25.S06 seeds. However, at shallow distances, there were some dosimetric differences between the AgX100 and 6711 seed, which warrant separate TG-43U1 parameters for use in clinical treatment planning systems.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Firas Mourtada, Justin Mikell, Geoffrey Ibbott,